NCT00090389

Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of acupuncture in treating women's health conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Jan 2005

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 25, 2004

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 26, 2004

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2005

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2007

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2007

Completed
Last Updated

January 25, 2008

Status Verified

January 1, 2008

Enrollment Period

2.3 years

First QC Date

August 25, 2004

Last Update Submit

January 23, 2008

Conditions

Ovarian NeoplasmsEndometriosisPelvic PainUterine Neoplasms

Keywords

AcupunctureMedicine, Chinese Traditional

Interventions

Chinese AcupuncturePROCEDURE

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Newly diagnosed ovarian cancer; primary peritoneal cancer; papillary serous cancer of the endometrium; or mixed mesodermal tumor of the uterus, ovary, or fallopian tube
  • Currently undergoing chemotherapy
  • Meet certain laboratory test requirements
  • Currently closed to recruitment
  • Diagnosed with endometriosis or unspecified pelvic pain

You may not qualify if:

  • Use of white blood cell boosters
  • Prior radiotherapy with the exception of whole-breast irradiation for breast cancer
  • Prior myelotoxic chemotherapy
  • History of symptomatic cardiac or psychiatric disorder
  • Use of a pacemaker
  • Use of herbs or herbal supplements
  • Prior use of acupuncture
  • Enrollment in other research studies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dana Farber Cancer Institute

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Ovarian NeoplasmsEndometriosisPelvic PainUterine Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal DisordersPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsUterine Diseases

Study Officials

  • Peter Wayne, PhD

    New England School of Acupuncture

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH

Study Record Dates

First Submitted

August 25, 2004

First Posted

August 26, 2004

Study Start

January 1, 2005

Primary Completion

May 1, 2007

Study Completion

May 1, 2007

Last Updated

January 25, 2008

Record last verified: 2008-01

Locations

US(1)